Finland Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2017

Report Overview

Table of Contents

1646.17

Select License Type

£1,646.17	Electronic License Electronic License An electronic version (mostly PDF, but can be Excel or PPT), which is either available for immediate download or will be sent via email by the Publisher of the report. The licencing for an electronic version is for use by the purchaser ONLY.
£3,292.33	Site License Site License An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is intended for use by more than one individual, across for example, a site, an office, or a division or country.
£4,938.50	Corporate License Corporate License An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is/are intended for use by an organisation in its entirety. For example, if reports are put on an Intranet or if they are distributed or used by more than one office, division, or country operation, then a Corporate Licence is required.

£1,646.17	Add to Wishlist
Change Currency	GBP EURO USD
	Order By Fax

Market	Healthcare and Medical
Report Type	Market Research
Country	Finland
Published	26 May 2011
Number of Pages	84
Report Delivery	Email
Delivery Lead Time	1-3 hours, 24 hour max
Publisher	Global Markets Direct
File Format	-

Finland Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2017 - "Finland Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2017", a new report, provides key market data on the Finland Drug Delivery Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within four market categories – Central Venous Catheters, Infusion Systems, Inhalation Systems, Metered Dose Inhaler Devices and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on key recent developments.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by our team of industry experts.

Scope

- Market size and company share data for Drug Delivery Devices market categories – Central Venous Catheters, Infusion Systems, Inhalation Systems, Metered Dose Inhaler Devices and Needle Free Injections.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within four market categories. Data from 2003 to 2010, forecast forward for 7 years to 2017.
- 2010 company shares and distribution shares data for each of the four market categories.
- Global corporate-level profiles of key companies operating within the Finland Drug Delivery Devicesmarket.
- Key players covered include GlaxoSmithKline plc, Boehringer Ingelheim GmbH, AstraZeneca PLC, Baxter International Inc., B. Braun Melsungen AG, Sunovion and others.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Finland Drug Delivery Devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and whats the most preferred mode of product distribution – Identify, understand and capitalize.

Speak to an Advisor

Call us on
+44 (0) 203 086 8600

Select License Type

£1,646.17	Electronic License Electronic License An electronic version (mostly PDF, but can be Excel or PPT), which is either available for immediate download or will be sent via email by the Publisher of the report. The licencing for an electronic version is for use by the purchaser ONLY.
£3,292.33	Site License Site License An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is intended for use by more than one individual, across for example, a site, an office, or a division or country.
£4,938.50	Corporate License Corporate License An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is/are intended for use by an organisation in its entirety. For example, if reports are put on an Intranet or if they are distributed or used by more than one office, division, or country operation, then a Corporate Licence is required.

£1,646.17	Add to Wishlist
Change Currency	GBP EURO USD

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 8
2 Introduction 9
2.1 What is This Report About? 9
3 Drug Delivery Devices In Finland 10
3.1 Drug Delivery Devices, Finland, Overall Revenue ($m), 2003-2017 10
3.2 Drug Delivery Devices, Finland, Category Volume (Units), 2003-2017 16
3.3 Drug Delivery Devices, Finland, Company Share (2009-2010) 21
4 Central Venous Catheters In Finland 23
4.1 Central Venous Catheters Overall Revenue (2003-2017) 23
4.2 Central Venous Catheters Overall Volume (2003-2017) 27
4.3 Central Venous Catheters Average Price (2003-2017) 29
4.4 Central Venous Catheters Distribution Share (2009-2010) 30
4.5 Central Venous Catheters, Finland, Company Share (2009-2010) 31
5 Infusion Systems In Finland 33
5.1 Infusion Systems Overall Revenue (2003-2017) 33
5.1.1 Syringe Pumps Revenue (2003-2017) 37
5.1.2 Ambulatory Infusion Pumps Revenue (2003-2017) 39
5.2 Infusion Systems Overall Volume (2003-2017) 43
5.2.1 Syringe Pumps Volume (2003-2017) 47
5.2.2 Ambulatory Infusion Pumps Volume (2003-2017) 49
5.3 Infusion Systems Average Price (2003-2017) 52
5.4 Infusion Systems Distribution Share (2009-2010) 53
5.5 Infusion Systems, Finland, Company Share (2009-2010) 54
6 Metered Dose Inhaler Devices In Finland 56
6.1 Metered Dose Inhaler Devices Overall Revenue (2003-2017) 56
6.2 Metered Dose Inhaler Devices Overall Volume (2003-2017) 58
6.3 Metered Dose Inhaler Devices Average Price (2003-2017) 60
6.4 Metered Dose Inhaler Devices Distribution Share (2009-2010) 61
6.5 Metered Dose Inhaler Devices, Finland, Company Share (2009-2010) 62
7 Needle Free Injections In Finland 64
7.1 Needle Free Injections Overall Revenue (2003-2017) 64
7.2 Needle Free Injections Overall Volume (2003-2017) 66
7.3 Needle Free Injections Average Price (2003-2017) 68
7.4 Needle Free Injections Distribution Share (2009-2010) 69
7.5 Needle Free Injections, Finland, Company Share (2009-2010) 70
8 Overview of Key Companies in Finland Drug Delivery Devices Market 71
8.1 GlaxoSmithKline plc 71
8.1.1 Company Overview 71
8.2 Boehringer Ingelheim GmbH 71
8.2.1 Company Overview 71
8.3 AstraZeneca PLC 71
8.3.1 Company Overview 71
8.4 Baxter International Inc. 72
8.4.1 Company Overview 72
8.5 B. Braun Melsungen AG 72
8.5.1 Company Overview 72
8.6 Hospira, Inc. 72
8.6.1 Company Overview 72
8.7 Medtronic, Inc. 73
8.7.1 Company Overview 73
8.8 Teleflex Incorporated 73
8.8.1 Company Overview 73
8.9 Fresenius Kabi AG 73
8.9.1 Company Overview 73
8.10 CareFusion Corporation 74
8.10.1 Company Overview 74
8.11 Smiths Medical 74
8.11.1 Company Overview 74
8.12 Terumo Corporation 74
8.12.1 Company Overview 74
8.13 3M Health Care 75
8.13.1 Company Overview 75
8.14 Edwards Lifesciences Corporation 75
8.14.1 Company Overview 75
8.15 Consort Medical plc 75
8.15.1 Company Overview 75
8.16 Becton, Dickinson and Company 76
8.16.1 Company Overview 76
8.17 C. R. Bard, Inc. 76
8.17.1 Company Overview 76
8.18 INJEX - Equidyne Systems 76
8.18.1 Company Overview 76
8.19 Antares Pharma, Inc. 77
8.19.1 Company Overview 77
8.20 Bioject Medical Technologies Inc. 77
8.20.1 Company Overview 77
9 Appendix 78
9.1 Global Markets Direct Research Methodology 78
9.2 Definitions of Markets Covered in the Report 79
9.2.1 Drug Delivery Devices 79
9.3 Secondary Research 82
9.4 Primary Research 82
9.5 Models 83
9.6 Forecasts 83
9.7 Expert Panel Validation 83
9.8 Currency Conversion 84
9.9 Contact Us 84
9.10 Disclaimer 84

List of Tables

Table 1: Drug Delivery Devices, Finland, Overall Revenue ($m), 2003-2017 11
Table 2: Drug Delivery Devices, Finland, Overall Revenue ($m), Historic, 2003-2010 13
Table 3: Drug Delivery Devices, Finland, Overall Revenue ($m), Forecast, 2010-2017 15
Table 4: Drug Delivery Devices, Finland, Category Volume (Units), 2003-2017 16
Table 5: Drug Delivery Devices, Finland, Category Volume (Units), Historic, 2003-2010 18
Table 6: Drug Delivery Devices, Finland, Category Volume (Units), Forecast, 2010-2017 20
Table 7: Drug Delivery Devices, Finland, Company Share by Revenue ($m), 2009-2010 22
Table 8: Central Venous Catheters, Finland, Revenue ($m) by Segment, Historic, 2003-2010 24
Table 9: Central Venous Catheters, Finland, Revenue ($m) by Segment, Forecast, 2010-2017 26
Table 10: Central Venous Catheters, Finland, Volume (Units) by Segment, Historic, 2003-2010 27
Table 11: Central Venous Catheters, Finland, Volume (Units) by Segment, Forecast, 2010-2017 28
Table 12: Central Venous Catheters, Finland, Average Price ($), Historic, 2003-2010 29
Table 13: Central Venous Catheters, Finland, Average Price ($), Forecast, 2010-2017 29
Table 14: Central Venous Catheters, Finland, Distribution Share by Revenue ($m), 2009-2010 30
Table 15: Central Venous Catheters, Finland, Company Share by Revenue ($m), 2009-2010 32
Table 16: Infusion Systems, Finland, Revenue ($m) by Segment, Historic, 2003-2010 34
Table 17: Infusion Systems, Finland, Revenue ($m) by Segment, Forecast, 2010-2017 36
Table 18: Syringe Pumps, Finland, Revenue ($m) by Sub-Segment, Historic, 2003-2010 37
Table 19: Syringe Pumps, Finland, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 38
Table 20: Ambulatory Infusion Pumps, Finland, Revenue ($m) by Sub-Segment, Historic, 2003-2010 40
Table 21: Ambulatory Infusion Pumps, Finland, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 42
Table 22: Infusion Systems, Finland, Volume (Units) by Segment, Historic, 2003-2010 44
Table 23: Infusion Systems, Finland, Volume (Units) by Segment, Forecast, 2010-2017 46
Table 24: Syringe Pumps, Finland, Volume (Units) by Sub-Segment, Historic, 2003-2010 47
Table 25: Syringe Pumps, Finland, Volume (Units) by Sub-Segment, Forecast, 2010-2017 48
Table 26: Ambulatory Infusion Pumps, Finland, Volume (Units) by Sub-Segment, Historic, 2003-2010 50
Table 27: Ambulatory Infusion Pumps, Finland, Volume (Units) by Sub-Segment, Forecast, 2010-2017 51
Table 28: Infusion Systems, Finland, Average Price ($), Historic, 2003-2010 52
Table 29: Infusion Systems, Finland, Average Price ($), Forecast, 2010-2017 52
Table 30: Infusion Systems, Finland, Distribution Share by Revenue ($m), 2009-2010 53
Table 31: Infusion Systems, Finland, Company Share by Revenue ($m), 2009-2010 55
Table 32: Metered Dose Inhaler Devices, Finland, Revenue ($m), Historic, 2003-2010 56
Table 33: Metered Dose Inhaler Devices, Finland, Revenue ($m), Forecast, 2010-2017 57
Table 34: Metered Dose Inhaler Devices, Finland, Volume (Units), Historic, 2003-2010 58
Table 35: Metered Dose Inhaler Devices, Finland, Volume (Units), Forecast, 2010-2017 59
Table 36: Metered Dose Inhaler Devices, Finland, Average Price ($), Historic, 2003-2010 60
Table 37: Metered Dose Inhaler Devices, Finland, Average Price ($), Forecast, 2010-2017 60
Table 38: Metered Dose Inhaler Devices, Finland, Distribution Share by Revenue ($m), 2009-2010 61
Table 39: Metered Dose Inhaler Devices, Finland, Company Share by Revenue ($m), 2009-2010 63
Table 40: Needle Free Injections, Finland, Revenue ($m), Historic, 2003-2010 64
Table 41: Needle Free Injections, Finland, Revenue ($m), Forecast, 2010-2017 65
Table 42: Needle Free Injections, Finland, Volume (Units), Historic, 2003-2010 66
Table 43: Needle Free Injections, Finland, Volume (Units), Forecast, 2010-2017 67
Table 44: Needle Free Injections, Finland, Average Price ($), Historic, 2003-2010 68
Table 45: Needle Free Injections, Finland, Average Price ($), Forecast, 2010-2017 68
Table 46: Needle Free Injections, Finland, Distribution Share by Revenue ($m), 2009-2010 69
Table 47: Needle Free Injections, Finland, Company Share by Revenue ($m), 2009-2010 70
Table 48: USD to Local Currency, Finland, Average Actual Rate 2003-2010 84

List of Figures

Figure 1: Drug Delivery Devices, Finland, Overall Revenue ($m), 2003-2017 10
Figure 2: Drug Delivery Devices, Finland, Overall Revenue ($m), Historic, 2003-2010 12
Figure 3: Drug Delivery Devices, Finland, Overall Revenue ($m), Forecast, 2010-2017 14
Figure 4: Drug Delivery Devices, Finland, Category Volume (Units), 2003-2017 16
Figure 5: Drug Delivery Devices, Finland, Category Volume (Units), Historic, 2003-2010 17
Figure 6: Drug Delivery Devices, Finland, Category Volume (Units), Forecast, 2010-2017 19
Figure 7: Drug Delivery Devices, Finland, Company Share (%), 2010 21
Figure 8: Central Venous Catheters, Finland, Revenue ($m) by Segment, Historic, 2003-2010 23
Figure 9: Central Venous Catheters, Finland, Revenue ($m) by Segment, Forecast, 2010-2017 25
Figure 10: Central Venous Catheters, Finland, Volume (Units) by Segment, Historic, 2003-2010 27
Figure 11: Central Venous Catheters, Finland, Volume (Units) by Segment, Forecast, 2010-2017 28
Figure 12: Central Venous Catheters, Finland, Company Share (%), 2010 31
Figure 13: Infusion Systems, Finland, Revenue ($m) by Segment, Historic, 2003-2010 33
Figure 14: Infusion Systems, Finland, Revenue ($m) by Segment, Forecast, 2010-2017 35
Figure 15: Syringe Pumps, Finland, Revenue ($m) by Sub-Segment, Historic, 2003-2010 37
Figure 16: Syringe Pumps, Finland, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 38
Figure 17: Ambulatory Infusion Pumps, Finland, Revenue ($m) by Sub-Segment, Historic, 2003-2010 39
Figure 18: Ambulatory Infusion Pumps, Finland, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 41
Figure 19: Infusion Systems, Finland, Volume (Units) by Segment, Historic, 2003-2010 43
Figure 20: Infusion Systems, Finland, Volume (Units) by Segment, Forecast, 2010-2017 45
Figure 21: Syringe Pumps, Finland, Volume (Units) by Sub-Segment, Historic, 2003-2010 47
Figure 22: Syringe Pumps, Finland, Volume (Units) by Sub-Segment, Forecast, 2010-2017 48
Figure 23: Ambulatory Infusion Pumps, Finland, Volume (Units) by Sub-Segment, Historic, 2003-2010 49
Figure 24: Ambulatory Infusion Pumps, Finland, Volume (Units) by Sub-Segment, Forecast, 2010-2017 51
Figure 25: Infusion Systems, Finland, Company Share (%), 2010 54
Figure 26: Metered Dose Inhaler Devices, Finland, Revenue ($m), Historic, 2003-2010 56
Figure 27: Metered Dose Inhaler Devices, Finland, Revenue ($m), Forecast, 2010-2017 57
Figure 28: Metered Dose Inhaler Devices, Finland, Volume (Units), Historic, 2003-2010 58
Figure 29: Metered Dose Inhaler Devices, Finland, Volume (Units), Forecast, 2010-2017 59
Figure 30: Metered Dose Inhaler Devices, Finland, Company Share (%), 2010 62
Figure 31: Needle Free Injections, Finland, Revenue ($m), Historic, 2003-2010 64
Figure 32: Needle Free Injections, Finland, Revenue ($m), Forecast, 2010-2017 65
Figure 33: Needle Free Injections, Finland, Volume (Units), Historic, 2003-2010 66
Figure 34: Needle Free Injections, Finland, Volume (Units), Forecast, 2010-2017 67
Figure 35: Needle Free Injections, Finland, Company Share (%), 2010 70
Figure 36: Global Markets Direct Methodology 78

Companies Mentioned

GlaxoSmithKline plc
Boehringer Ingelheim GmbH
AstraZeneca PLC
Baxter International Inc.
B. Braun Melsungen AG
Hospira, Inc.
Medtronic, Inc.
Teleflex Incorporated
Fresenius Kabi AG
CareFusion Corporation
Smiths Medical
Terumo Corporation
3M Health Care
Edwards Lifesciences Corporation
Consort Medical plc
Becton, Dickinson and Company
C. R. Bard, Inc.
INJEX - Equidyne Systems
Antares Pharma, Inc.
Bioject Medical Technologies Inc.

Visitor Comments

All Comments

Change Currency

GBP

EURO

USD

Last Viewed

Finland Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2017

Healthcare and Medical Company Profiles

Find latest Healthcare and Medical Company Profiles with up to date financial, strategic, operational, SWOT analysis and product information for the leading healthcare and medical companies.

Competitor Tracking

Do you need to track your competitors and customers on a continuous basis? We have the expertise to provide you with a cost-effective, fully customised competitor tracking portal, which collates data on your competitors on a continuous basis. Contact us for a free consultation and demonstration.

Become an Affiliate

Do you manage an industry specific website or blog? Are you looking to monetise your web traffic further? Are you a B2B website?

Why not offer your visitors industry specific strategic market reports and company profiles? Our Affiliate Program enables you to provide quality content on your website and to earn money from passing on visitors to our website.

Custom Research

Cannot find what you need? We can tailor a report for you. Complete the Custom Research Form and we will provide a quote.

Healthcare and Medical	Type	Keywords Phrase All Words Any Word
Microsoft Windows users can hold the CTRL Key to select more than one sector or country at a time. Apple users can hold the CMD Key to do the same.	Country	Industry Sector
Publisher	Order By Relevance Date	Published In

Finland Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2017

Select License Type

Speak to an Advisor

Select License Type

Table of Contents

Visitor Comments

Change Currency

Last Viewed

Healthcare and Medical Company Profiles

Competitor Tracking

Become an Affiliate

Custom Research

News

Market Insights

Companies And Markets

Customer Support

Corporate Accounts

Contact Details

Contrast settings

Text size settings

All
Afghanistan
Africa
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antigua and Barbuda
Argentina
Armenia
Aruba
Asia
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia-Herzegovina
Botswana
Bouvet Island
Brazil
British Virgin Islands
Brunei
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Caribbean
Cayman Islands
Central African Republic
Central America
Central Europe
Chad
Chile
China
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Conch Republic
Cook Islands
Costa Rica
Croatia
Cuba
Cyprus
Czech Republic
Democratic Republic of the Congo
Denmark
Djibouti
Dominica
Dominican Republic
Eastern Europe
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Europe
Falkland Islands
Faroe Islands
Fiji
Finland
France
French Guiana
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Global
Greece
Greenland
Grenada
Guadeloupe (French)
Guam (USA)
Guatemala
Guernsey
Guinea
Guinea Bissau
Guyana
Haiti
Heard Island and McDonald Islans
Holy See
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran
Iraq
Ireland
Israel
Italy
Ivory Coast
Ivory Coast (Cote D`Ivoire)
Jamaica
Japan
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
Kurdistan
Kuwait
Kyrgyzstan
Laos
Latvia
Lebanon
Lesotho
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Macau
Macedonia
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique (French)
Mauritania
Mauritius
Mayotte
Mexico
Micronesia
Middle East
Moldova
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
Netherlands Antilles
New Caledonia (French)
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
North America
North Korea
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Palestinian Territory
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn Island
Poland
Polynesia (French)
Portugal
Puerto Rico
Qatar
Republic of the Congo
Reunion
Romania
Russia
Rwanda
Saint Barthelemy
Saint Helena
Saint Kitts and Nevis
Saint Lucia
Saint Martin
Saint Pierre and Miquelon
Saint Vincent and Grenadines
Samoa
San Marino
Sao Tome and Principe
Saudi Arabia
Scandinavia
Schengen countries
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South America
South Georgia and the South Sandwich Islands
South Korea
South Sudan
Spain
Sri Lanka
Sudan
Suriname
Svalbard and Jan Mayen Islands
Swaziland
Sweden
Switzerland
Syria
Taiwan
Tajikistan
Tanzania
Thailand
Timor-Leste (East Timor)
Togo
Tokelau
Tonga
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Turks and Caicos Islands
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States
United States Minor Outlying Islands
Uruguay
Uzbekistan
Vanuatu
Venezuela
Vietnam
Virgin Islands
Wallis and Futuna Islands
Western Sahara
Yemen
Zambia
Zimbabwe

All
Aerospace
Agriculture, Farming & Raw Materials
Automotive and Parts
Business Services
Chemicals
Construction
Consumer Goods
Defence
Energy and Utilities
Environmental
Finance and Banking
Food and Drink
Healthcare and Medical
Industrial
Information Technology
Leisure
Logistics
Media
Paper and Packaging
Publishing and Printing
Real Estate
Retail
Security
Telecommunications
Textiles and Clothing
Transportation
Travel